Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.6000 (1.63%) ($5.3600 - $5.6000) on Tue. Jul. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 38 | Latest Price | $5.6000(1.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.4% a day on average for past five trading days. | Weekly Trend | ANPC declines -1.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) LIT(9%) IGOV(8%) IPO(7%) OIH(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.415% in a week (0% probabilities). SHY(-19%) IBB(-10%) XBI(-9%) XLU(-7%) TBT(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.57(-270.89%) | Resistance Level | $5.61 | 5 Day Moving Average | $5.34(4.87%) | 10 Day Moving Average | $5.46(2.56%) | 20 Day Moving Average | $5.61(-0.18%) | To recent high | -32.4% | To recent low | 10% | Market Cap | $48m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |